Causes of resistance and treatment choices of second- and third-line treatment in chronic myelogenous leukemia patients.
about
Catch me if you can: Leukemia Escape after CD19-Directed T Cell ImmunotherapiesTyrosine kinase inhibitors and mesenchymal stromal cells: effects on self-renewal, commitment and functionsA Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian CancerChemopreventive Effects of Dietary Eicosapentaenoic Acid Supplementation in Experimental Myeloid Leukemia.Short overview on the current treatment of chronic myeloid leukemia in chronic phaseAddressing intra-tumoral heterogeneity and therapy resistance.Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy.Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.Physicians' attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients.Pharmacology and pharmacokinetics of imatinib in pediatric patients.Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients.
P2860
Q28072131-EAB8E5FC-26C7-46DC-8854-F529A788C9C6Q28078946-88D3082F-CCAE-4ED2-BCCE-0B0E4BB87169Q28551341-E2B33092-6500-417E-9436-3247392B19F5Q36132830-3071D9C7-DF5F-4F10-94EA-786CD32B9B8FQ37512201-5B17AF0C-9737-4050-A04F-B4D957ED63E3Q38823179-B6ABBC8F-5EF7-4C24-9179-E7F9F171F2E5Q38843265-EBC0512A-B6BE-4040-95A3-0E6314FC7AF8Q40607863-3368EB77-B660-46CC-A6AD-D709E52E560AQ42672393-715B3072-2EC7-4780-A146-87C66938DBB2Q50094239-A26FB5BA-2B30-476D-84B8-EECDB5A244BCQ54119186-8F8CB621-9282-4DEA-9BCD-2228A24608C0
P2860
Causes of resistance and treatment choices of second- and third-line treatment in chronic myelogenous leukemia patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Causes of resistance and treat ...... myelogenous leukemia patients.
@en
type
label
Causes of resistance and treat ...... myelogenous leukemia patients.
@en
prefLabel
Causes of resistance and treat ...... myelogenous leukemia patients.
@en
P2860
P1433
P1476
Causes of resistance and treat ...... myelogenous leukemia patients.
@en
P2093
Ekkehard Eigendorff
Thomas Ernst
P2860
P304
P356
10.1007/S00277-015-2323-1
P478
94 Suppl 2
P577
2015-03-27T00:00:00Z